Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The J3s had a 80% chance they would pay ZERO, so why should they settle?

The one fact that you overlooked was that licenses were granted, and priced, on the basis of "downstream payments."

The solution is therefore simple, go back to the manufacurers and claim a per chip royalty.

 

 

Be well

Share
New Message
Please login to post a reply